Rucaparib is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Rucaparib is used to treat advanced ovarian cancer.
Rucaparib is used only if your tumor has a specific genetic marker, for which your doctor will test.
caparib is usually given after at least 2 other cancer medicines have been tried without success.
Rucaparib may also be used for purposes not listed in this medication guide.
Rucaparib can cause leukemia or serious bone marrow problems. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, blood in your urine or stools, shortness of breath, or signs of infection (fever, feeling weak or tired, weight loss).
Rucaparib is a type of drug called a PARP inhibitor, which prevents cells from repairing damage to their DNA. Rucaparib joins olaparib (Lynparza) and niraparib (Zejula) as the third PARP inhibitor to be approved as a maintenance therapy for women with recurrent ovarian, fallopian tube, or primary peritoneal cancers that still respond to platinum-based chemotherapies.
